Who has invested in Novocardia?

Deerfield Management Company are named among the investors backing Novocardia.

Novocardia Funding: $54M Raised, Series A

Novocardia funding overview

Novocardia is based in New York City. Novocardia has raised $54M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A. Investors on record include Deerfield Management Company.

Novocardia at a glance

Total raised: $54M
Latest round: Series A
Headquarters: New York City
Notable investors: Deerfield Management Company

Frequently asked about Novocardia funding

How much has Novocardia raised?: Novocardia has raised $54M in total disclosed funding across the rounds on record.
Who has invested in Novocardia?: Deerfield Management Company are named among the investors backing Novocardia.
What was the latest Novocardia funding round?: The most recent disclosed round is a Series A.
Where is Novocardia based?: Novocardia is based in New York City.

Round data for Novocardia is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in New York City and backer lists below.

Novocardia Funding: $54M Raised, Series A

Novocardia funding overview

Novocardia at a glance

Frequently asked about Novocardia funding

Companies related to Novocardia (29)

Browse related funding lists (3)